InvestSMART

BARD1 Life Sciences Limited (ASX: BD1) - Announcements

Current share price for BD1 : $1.035 0.01 (0.98%)+

ASX company news and announcements for BARD1 Life Sciences Limited (BD1) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All BARD1 Life Sciences Limited (BD1) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than BARD1 Life Sciences Limited (BD1), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for BARD1 Life Sciences Limited (BD1)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Grant of Additional Chinese Patent Core BARD1 Patent Family 24 Oct 2018 1:20PM $0.051 $1.035 risen by 1,929.41%
- Development of world first BARD1 Breast Cancer Test 23 Oct 2018 1:22PM $0.013 $1.035 risen by 7,861.54%
- Appendix 4G 1 Oct 2018 8:48AM $0.011 $1.035 risen by 9,309.09%
- Annual Report to Shareholders 1 Oct 2018 8:48AM $0.011 $1.035 risen by 9,309.09%
- Investor Presentation and Update 20 Sep 2018 11:27AM $0.011 $1.035 risen by 9,309.09%
- Ceasing to be a substantial holder 10 Sep 2018 6:12PM $0.012 $1.035 risen by 8,525%
- Bard1 Ovarian Test Results 6 Sep 2018 11:37AM $0.012 $1.035 risen by 8,525%
- Appendix 4E 31 Aug 2018 5:18PM $0.013 $1.035 risen by 7,861.54%
- Final Director's Interest Notice 21 Aug 2018 12:12PM $0.013 $1.035 risen by 7,861.54%
- Death of Non-Executive Director 13 Aug 2018 9:29AM $0.013 $1.035 risen by 7,861.54%
- Quarterly Activities Report and Appendix 4C 1 Aug 2018 8:37AM $0.015 $1.035 risen by 6,800%
- US Patent Issued Protecting BARD1 Ovarian Test 12 Jul 2018 9:31AM $0.015 $1.035 risen by 6,800%
- Appendix 3B Release of Securities from Escrow 21 Jun 2018 5:48PM $0.014 $1.035 risen by 7,292.86%
- Improved Performance of BARD1 Ovarian Test 19 Jun 2018 10:00AM $0.019 $1.035 risen by 5,347.37%
- Notice under ASX Listing Rule 3.10A 8 Jun 2018 10:24AM $0.015 $1.035 risen by 6,800%
- Reinstatement to Official Quotation 18 May 2018 3:11PM $0.020 $1.035 risen by 5,075%
- Response to ASX Price Query 18 May 2018 3:11PM $0.020 $1.035 risen by 5,075%
- Contract Development Agreement Signed 18 May 2018 3:00PM $0.020 $1.035 risen by 5,075%
- Voluntary Suspension 14 May 2018 10:07AM $0.020 $1.035 risen by 5,075%
- Trading Halt 10 May 2018 10:30AM $0.020 $1.035 risen by 5,075%
- Quarterly Business Update and Appendix 4C 30 Apr 2018 2:59PM $0.016 $1.035 risen by 6,368.75%
- Becoming a substantial holder 19 Apr 2018 4:00PM $0.015 $1.035 risen by 6,800%
- Appendix 3B and Cleansing Statement 28 Mar 2018 9:39AM $0.018 $1.035 risen by 5,650%
- Corporate Presentation 22 Mar 2018 9:30AM $0.023 $1.035 risen by 4,400%
- Capital Raising 22 Mar 2018 9:30AM $0.023 $1.035 risen by 4,400%

201 - 225 of 309 results

Page 9 of 13

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.